Renhuang Pharmaceuticals, Inc. (RHGP.OB)is the market leader in traditional OTC medicines and Acanthopanex-based products. Vertically integrated, Renhuan is a developer, manufacturer and distributor of high-quality nutraceutical, natural medicinal and bio-pharmaceutical products in mainland China. It offers three major product lines: Acanthopanax-based natural medicinal products, the Shark Power healthcare series and Traditional Chinese Medicines.
Renhuang has an established multi-channel research and development infrastructure in China. This infrastructure consists of approximately 50 in-house researchers and engineers, a post-doctoral work center approved and supported by the Chinese government, and collaborations with leading institutions and scientists.
Renhuang is China’s leading supplier of Acanthopanax-based natural medicines and controls 70% of China’s Acanthopanax resource, which is also known as Siberian Ginseng. The Company plans to distribute its products through China’s major drug store chains in urban and suburban markets, through top-tier hospitals and through a multi-layer network consisting of over 2,000 sales agents and 70 sales centers across 24 districts covering over 50% of China. Renhuang also plans to extend its distribution to Russia and Southeast Asia.
In September 2006, Renhuang acquired Harbin Renhuang Pharmaceutical Company Limited. The company later acquired all of the assets of Qingyang Herbal Extracting Factory in March 2007. The acquired Qingyang facility doubles the Company’s current herb extraction capacity and enables processing of approximately 18,000 tons of herbal raw materials. Renhuang strictly adheres to international Good Manufacturing Practices (GMP) production quality standards and has invested in cutting edge technologies.
Renhuang Pharmaceuticals is headquartered in Harbin located within the Heilongjiang Province in Northeast China. China’s demand for health care and pharmaceutical products is expected to rise significantly due to a rapidly growing middle class and an aging population. In addition to growing pharmaceutical needs, herbal medicines remain extremely popular with Chinese consumers and are gaining acceptance with consumers in Western countries as well.
Let us hear your thoughts: Renhuang Pharmaceuticals, Inc. Message Board